Trichomegaly of Eyelashes after Treatment with Erlotinib in Carcinoma Pancreas

Epidermal growth factor receptor (EGFR) inhibitors have been widely used for the treatment of epithelial malignancies. A wide spectrum of skin toxicities have been described in patients receiving EGFR inhibitors. Trichomegaly, especially of the eyelashes is a rare side effect of this therapy. We rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Goel, Varun, Raina, Shubhra, Chandragouda, D, Singh, Sajjan, Talwar, Vineet, Patnaik, Nivedita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124690/
https://www.ncbi.nlm.nih.gov/pubmed/25114450
http://dx.doi.org/10.4103/0974-7753.136755
_version_ 1782329657125765120
author Goel, Varun
Raina, Shubhra
Chandragouda, D
Singh, Sajjan
Talwar, Vineet
Patnaik, Nivedita
author_facet Goel, Varun
Raina, Shubhra
Chandragouda, D
Singh, Sajjan
Talwar, Vineet
Patnaik, Nivedita
author_sort Goel, Varun
collection PubMed
description Epidermal growth factor receptor (EGFR) inhibitors have been widely used for the treatment of epithelial malignancies. A wide spectrum of skin toxicities have been described in patients receiving EGFR inhibitors. Trichomegaly, especially of the eyelashes is a rare side effect of this therapy. We report a case of trichomegaly of eyelashes in a 39-year-old male, a case of carcinoma pancreas. This side-effect of these medications gives prospects as a therapy to stimulate the growth of hair.
format Online
Article
Text
id pubmed-4124690
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-41246902014-08-11 Trichomegaly of Eyelashes after Treatment with Erlotinib in Carcinoma Pancreas Goel, Varun Raina, Shubhra Chandragouda, D Singh, Sajjan Talwar, Vineet Patnaik, Nivedita Int J Trichology Case Report Epidermal growth factor receptor (EGFR) inhibitors have been widely used for the treatment of epithelial malignancies. A wide spectrum of skin toxicities have been described in patients receiving EGFR inhibitors. Trichomegaly, especially of the eyelashes is a rare side effect of this therapy. We report a case of trichomegaly of eyelashes in a 39-year-old male, a case of carcinoma pancreas. This side-effect of these medications gives prospects as a therapy to stimulate the growth of hair. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4124690/ /pubmed/25114450 http://dx.doi.org/10.4103/0974-7753.136755 Text en Copyright: © International Journal of Trichology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Goel, Varun
Raina, Shubhra
Chandragouda, D
Singh, Sajjan
Talwar, Vineet
Patnaik, Nivedita
Trichomegaly of Eyelashes after Treatment with Erlotinib in Carcinoma Pancreas
title Trichomegaly of Eyelashes after Treatment with Erlotinib in Carcinoma Pancreas
title_full Trichomegaly of Eyelashes after Treatment with Erlotinib in Carcinoma Pancreas
title_fullStr Trichomegaly of Eyelashes after Treatment with Erlotinib in Carcinoma Pancreas
title_full_unstemmed Trichomegaly of Eyelashes after Treatment with Erlotinib in Carcinoma Pancreas
title_short Trichomegaly of Eyelashes after Treatment with Erlotinib in Carcinoma Pancreas
title_sort trichomegaly of eyelashes after treatment with erlotinib in carcinoma pancreas
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124690/
https://www.ncbi.nlm.nih.gov/pubmed/25114450
http://dx.doi.org/10.4103/0974-7753.136755
work_keys_str_mv AT goelvarun trichomegalyofeyelashesaftertreatmentwitherlotinibincarcinomapancreas
AT rainashubhra trichomegalyofeyelashesaftertreatmentwitherlotinibincarcinomapancreas
AT chandragoudad trichomegalyofeyelashesaftertreatmentwitherlotinibincarcinomapancreas
AT singhsajjan trichomegalyofeyelashesaftertreatmentwitherlotinibincarcinomapancreas
AT talwarvineet trichomegalyofeyelashesaftertreatmentwitherlotinibincarcinomapancreas
AT patnaiknivedita trichomegalyofeyelashesaftertreatmentwitherlotinibincarcinomapancreas

Ejemplares similares